In 2025, IAS invested in the next generation, collaborated for impact, and fostered a global network for better prevention and care of atherosclerosis. This is all thanks to you, IAS members - 40,000 clinicians, 93 constituent societies in 93 countries!
There's much more in store for next year! Happy 2026 from IAS!
#ICYMI: Watch the latest episode of IAS’ Leading Insights series and hear Prof. Jessica M. Peña and Prof. Alexander van Rosendael discuss the latest study findings using CONFIRM2, the largest registry of quantification of atherosclerosis.
Watch to learn more: https://t.co/1uzlRcoqmW
IAS Board Member @MutazAlsabah, MD, joined the College of Pharmacy of the University of Al-Qadisiya in Iraq for their annual event on innovation.
During the event, Dr. Al-Sabah spoke about his work, co-authored with @rauldsf_santos, MD, PhD, highlighting premarital familial hypercholesterolemia and the hope it represents to reducing the burden of HoFH in areas like the Middle East and Africa.
🩺 Kids need cholesterol checks, too.
Standard recs: test once at 9–11, again at 17–21, and as early as age 2 if there’s a family history of early heart disease or FH.
🔎 Identify risk early + catch FH. Learn more: https://t.co/iDElJ5DHJB 💙
#FindFH
One week left!
Share your research with the global cardiovascular community at #EASCongress2026 in Athens (24–27 May 2026).
Present your findings and shape the future of atherosclerosis research.
📅 Deadline: 3 Dec 2025
🔗 https://t.co/U8P3Mk6RTo
Prof. Jeanine Roeters van Lennep reminds you that only one week remains until the abstract submission deadline: https://t.co/YodYCqMm8K @j_rvl@ProfKausikRay@KatiOorni
Our next station.
IAS will be in Pakistan next Monday to attend the opening of the first adult Lipid Clinic there.
Koohi Goth hospital in Karachi.
Thank you Dr Fauzia Sadiq and Dr. Faisal Ghani for the great work you both did to make this a sucess.
@atherosociety@SamiaMoraMD.
📅 MARK YOUR CALENDAR 📅
The 21st International Symposium on Atherosclerosis is scheduled for October 20-22, 2027 in Santiago, Chile!
#ISA2027 will bring together clinicians, scientists, policymakers and patient advocates from across the globe under the theme, "Cardiometabolic Health Unlocked: From Genetics to Global Impact."
Thank you to IAS member @ateros_chile for its partnership in co-hosting this event. Look for more information to be released soon!
See you in #Santiago!
#DYK? Assessing a cohort of patients from the CONFIRM2 Registry found use of AI-QCT resulted in improved risk stratification for:
🔴 Major adverse cardiovascular events
🔴 Myocardial infarction/death
Learn more: https://t.co/ChkF4gb8ZS
Launching STAGE 1 of @atherosociety project in Iraq ( Establishment of the first #Obesity center) in collaboration with the Health authority and medical education in Karbala.
We are so grateful for our colleagues in @novonordisk for their pivotal role in making the event a sucess
Episode 2 of IAS' 𝘓𝘦𝘢𝘥𝘪𝘯𝘨 𝘐𝘯𝘴𝘪𝘨𝘩𝘵𝘴 series is now LIVE!
Hear from professors Jessica M. Peña and Alexander van Rosendael (@ARrosendael) as they discuss the latest study findings using CONFIRM2, the largest registry of quantification of atherosclerosis.
Watch to learn more: https://t.co/1uzlRcnSxo
#DYK? Fibrates or niacin in combination with statins have not been shown to reduce macrovascular cardiovascular events and are primarily used for severe, or very high, triglyceride levels.
Learn more: https://t.co/KFfIrWSrFj #TGThursdays
It's #FHAwarenessDay!
Hear from IAS President Dirk Blom, MBChB, PhD, and Board Member Mutaz Al-Sabah, MD (@MutazAlsabah), as they speak about why #FHAwareness is so important.
Join IAS in support of a better understanding of #FH, increased diagnostic efforts and greater access to treatments.
Watch video to learn more: https://t.co/1eflpEFVYm #KnowFH